Enhancing immunity to HIV through APOBEC.
Department of Biochemistry, Molecular Biology and Biophysics, Institute for Molecular Virology and Beckman Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota 55455, USA. rsh@umn.edu
Reuben S
RS
Harris
D000071480:APOBEC-3G Deaminase; D019380:Anti-HIV Agents / Q000276:immunology / Q000627:therapeutic use*; D003564:Cytidine Deaminase / Q000235:genetics / Q000276:immunology*; D043525:Cytosine Deaminase / Q000037:antagonists & inhibitors* / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology*; D054320:vif Gene Products, Human Immunodeficiency Virus / Q000276:immunology*
D019380:Anti-HIV Agents; D054320:vif Gene Products, Human Immunodeficiency Virus; D043525:Cytosine Deaminase; D000071480:APOBEC-3G Deaminase; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase